Cyclophilins A, B, and C Role in Human T Lymphocytes Upon Inflammatory Conditions

Cyclophilins (Cyps) are a group of peptidyl-prolyl cis/trans isomerases that play crucial roles in regulatory mechanisms of cellular physiology and pathology in several inflammatory conditions. Their receptor, CD147, also participates in the development and progression of the inflammatory response. Nevertheless, the main function of Cyps and their receptor are yet to be deciphered. The release of CypA and the expression of the CD147 receptor in activated T lymphocytes were already described, however, no data are available about other Cyps in these cells. Therefore, in the present work intra and extracellular CypA, B and C levels were measured followed by induced inflammatory conditions. After activation of T lymphocytes by incubation with concanavalin A, both intra and extracellular Cyps levels and the CD147 membrane receptor expression were increased leading to cell migration towards circulating CypA and CypB as chemoattractants. When CypA was modulated by natural and synthetic compounds, the inflammatory cascade was avoided including T cell migration. Our results strengthen the relationship between CypA, B, and C, their receptor, and the inflammatory process in human T lymphocytes, associating CypC with these cells for the first time.

[1]  L. Botana,et al.  Crosstalk between cyclophilins and T lymphocytes in coronary artery disease. , 2021, Experimental cell research.

[2]  L. Botana,et al.  Cyclophilins in Ischemic Heart Disease: Differences Between Acute and Chronic Coronary Artery Disease Patients , 2020, Cardiology research.

[3]  L. Botana,et al.  Gracilin-Derivatives as Lead Compounds for Anti-inflammatory Effects , 2019, Cellular and Molecular Neurobiology.

[4]  L. Botana,et al.  High Serum Cyclophilin C levels as a risk factor marker for Coronary Artery Disease , 2019, Scientific Reports.

[5]  L. Botana,et al.  Simplified immunosuppressive and neuroprotective agents based on gracilin A , 2019, Nature Chemistry.

[6]  G. Tse,et al.  CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer , 2018, Journal of Clinical Pathology.

[7]  J. Mayo,et al.  Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes , 2018, Front. Immunol..

[8]  M. Zouhar,et al.  Cyclophilins: Less Studied Proteins with Critical Roles in Pathogenesis. , 2018, Phytopathology.

[9]  Ruiyan Zhang,et al.  Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome , 2017, Front. Endocrinol..

[10]  R. Kurosawa,et al.  Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Coronary Artery Disease , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[11]  J. M. Cifuentes,et al.  Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation , 2016, Front. Immunol..

[12]  Wael E Houssen,et al.  Identification of Spongionella compounds as cyclosporine A mimics. , 2016, Pharmacological research.

[13]  P. Steg,et al.  Future of the Prevention and Treatment of Coronary Artery Disease. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[14]  P. Stocki,et al.  Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules , 2015, PloS one.

[15]  Wael E Houssen,et al.  Spongionella Secondary Metabolites Regulate Store Operated Calcium Entry Modulating Mitochondrial Functioning in SH-SY5Y Neuroblastoma Cells , 2015, Cellular Physiology and Biochemistry.

[16]  Wael E Houssen,et al.  Gracilins: Spongionella-derived promising compounds for Alzheimer disease , 2015, Neuropharmacology.

[17]  M. Capogrossi,et al.  Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases. , 2015, Cardiovascular research.

[18]  V. Yong,et al.  The role of EMMPRIN in T cell biology and immunological diseases , 2015, Journal of leukocyte biology.

[19]  M. Bukrinsky.  Extracellular cyclophilins in health and disease , 2014, Biochimica et Biophysica Acta (BBA) - General Subjects.

[20]  P. Stocki,et al.  Depletion of Cyclophilins B and C Leads to Dysregulation of Endoplasmic Reticulum Redox Homeostasis* , 2014, The Journal of Biological Chemistry.

[21]  C. Schiene‐Fischer,et al.  Functional aspects of extracellular cyclophilins , 2014, Biological chemistry.

[22]  Anima Nanda,et al.  CD147: a novel modulator of inflammatory and immune disorders. , 2014, Current medicinal chemistry.

[23]  M. Gawaz,et al.  Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases. , 2014, Cardiovascular research.

[24]  V. Kutty,et al.  Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease , 2014, Cardiovascular Diabetology.

[25]  Wael E Houssen,et al.  Spongionella Secondary Metabolites Protect Mitochondrial Function in Cortical Neurons against Oxidative Stress , 2014, Marine drugs.

[26]  P. Marquet,et al.  Mapping cyclosporine-induced changes in protein secretion by renal cells using stable isotope labeling with amino acids in cell culture (SILAC). , 2012, Journal of proteomics.

[27]  K. Klingel,et al.  Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[28]  K. Morohashi,et al.  Cyclosporin A Associated Helicase-Like Protein Facilitates the Association of Hepatitis C Virus RNA Polymerase with Its Cellular Cyclophilin B , 2011, PloS one.

[29]  B. He,et al.  Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes. , 2010, Atherosclerosis.

[30]  E. Eisenmesser,et al.  Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics , 2010, Clinical and experimental immunology.

[31]  Gavin W K Wong,et al.  Effect of cyclosporine on blood pressure. , 2010, The Cochrane database of systematic reviews.

[32]  E. Eisenmesser,et al.  Cyclophilin – CD 147 interactions : a new target for anti-inflammatory therapeuticscei , 2010 .

[33]  Tetsuya Matoba,et al.  Cyclophilin A enhances vascular oxidative stress and development of angiotensin II-induced aortic aneurysms , 2009, Nature Medicine.

[34]  M. Bukrinsky,et al.  Targeting the chemotactic function of CD147 reduces collagen‐induced arthritis , 2009, Immunology.

[35]  P. Gallay.  Cyclophilin inhibitors. , 2009, Clinics in liver disease.

[36]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[37]  R. Thurmond,et al.  The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders. , 2007, Pharmacology & therapeutics.

[38]  M. Bukrinsky,et al.  Extracellular Cyclophilins Contribute to the Regulation of Inflammatory Responses1 , 2005, The Journal of Immunology.

[39]  M. Bukrinsky,et al.  Regulation of CD147 Cell Surface Expression , 2005, Journal of Biological Chemistry.

[40]  Liang Xie,et al.  Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[41]  M. Bukrinsky,et al.  Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147* , 2002, The Journal of Biological Chemistry.

[42]  C. Vanpouille,et al.  Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Bennett,et al.  Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies , 2001, Current opinion in critical care.

[44]  M. Bukrinsky,et al.  CD147 is a signaling receptor for cyclophilin B. , 2001, Biochemical and biophysical research communications.

[45]  A. Rot,et al.  Presence of Cyclophilin A in Synovial Fluids of Patients with Rheumatoid Arthritis , 1997, The Journal of experimental medicine.

[46]  F. Marumo,et al.  Localization of cyclophilin A and cyclophilin C mRNA in murine kidney using RT-PCR. , 1994, Kidney international.

[47]  J. Milner,et al.  Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin. , 1992, Immunology.